Edwards Lifesciences Corporation revenue by segment EW

Annual Quarterly

Edwards Lifesciences Corporation splits its revenue into 3 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Transcatheter Aortic Valve Replacement at $1.2 billion, 72% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2026	Q3 FY2026 Sep 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024
Revenue	6,675	1,716	1,741	1,649	1,570	1,553	1,532	1,413	1,386
Transcatheter Aortic Valve Replacement	4,858 +11.3% share 72.8%	1,242 +8.0% share 72.4%	1,258 +11.3% share 72.3%	1,197 +14.4% share 72.6%	1,160 +12.0% share 73.9%	1,150 share 74.0%	1,131 share 73.8%	1,047 share 74.1%	1,036 share 74.8%
Surgical	1,078 +5.7% share 16.2%	264 +2.5% share 15.4%	284 +6.5% share 16.3%	276 +10.1% share 16.8%	254 +3.8% share 16.2%	258 share 16.6%	267 share 17.4%	251 share 17.8%	244 share 17.6%
Transcatheter Mitral And Tricuspid Therapies	739 +47.8% share 11.1%	210 +44.3% share 12.2%	199 +47.7% share 11.4%	175 +52.0% share 10.6%	156 +48.1% share 9.9%	145 share 9.3%	134 share 8.8%	115 share 8.2%	105 share 7.6%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as: EW (NYSE)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Irvine, CA
SEC filer status: Large accelerated filer
SEC CIK: 1099800
Former names: CVG CONTROLLED INC (until Jan 21, 2000)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.